These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 15918781)
1. Hepatitis C virus infection: the new global epidemic. Butt AA Expert Rev Anti Infect Ther; 2005 Apr; 3(2):241-9. PubMed ID: 15918781 [TBL] [Abstract][Full Text] [Related]
2. Consensus guidelines for the management of hepatitis C infection. Consensus Guidelines Committee for the Management of Hepatitis C Infection Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of hepatitis C virus infection]. Zeuzem S Praxis (Bern 1994); 2005 May; 94(18):721-6. PubMed ID: 15938383 [TBL] [Abstract][Full Text] [Related]
4. Therapy of hepatitis C: from empiricism to eradication. Pawlotsky JM Hepatology; 2006 Feb; 43(2 Suppl 1):S207-20. PubMed ID: 16447262 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C and treatment with pegylated interferon and ribavirin. Gotto J; Dusheiko GM Int J Biochem Cell Biol; 2004 Oct; 36(10):1874-7. PubMed ID: 15203100 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C: epidemiology, diagnosis, natural history and therapy. Pol S; Vallet-Pichard A; Corouge M; Mallet VO Contrib Nephrol; 2012; 176():1-9. PubMed ID: 22310776 [TBL] [Abstract][Full Text] [Related]
7. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy. Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854 [TBL] [Abstract][Full Text] [Related]
13. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553 [TBL] [Abstract][Full Text] [Related]
14. Interferon for hepatitis C patients with psychiatric disorders. Rifai MA; Bozorg B; Rosenstein DL Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919 [No Abstract] [Full Text] [Related]
15. Update on the treatment of chronic hepatitis C in HIV-infected patients. Soriano V; Barreiro P; Martin-Carbonero L; Vispo E; Garcia-Samaniego J; Labarga P; Gonzalez-Lahoz J AIDS Rev; 2007; 9(2):99-113. PubMed ID: 17694677 [TBL] [Abstract][Full Text] [Related]
16. Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon. Herrmann E; Lee JH; Marinos G; Modi M; Zeuzem S Hepatology; 2003 Jun; 37(6):1351-8. PubMed ID: 12774014 [TBL] [Abstract][Full Text] [Related]
17. Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation. Mukherjee S Transplant Proc; 2005 Dec; 37(10):4403-5. PubMed ID: 16387131 [TBL] [Abstract][Full Text] [Related]